Vivos Therapeutics (VVOS) Financials: Revenue & Earnings

VVOS price $0.12 -0.01 -3.90%

Ticker
VVOS
Price
$0.12
Change
-0.01 -3.90%
Market cap ?
$1.71M
P/E ?
-0.06
Dividend yield ?
0.00%
Beta ?
6.07
Sector
Healthcare
Industry
Medical - Devices
Stocklytics score
58
Value
59
Quality
15
Growth
100

Stocklytics score rationale: value 59, quality 15, growth 100.

Financials

20182019202020212022202320242025
379226111393277130660001688500016024000138010001503100017443000

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also…

Fair value

VVOS fair value Not meaningful. Price $0.12.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare VVOS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-18—-0.30—5.47M
2026-08-14-0.31-0.415.15M5.63M
2026-05-20-0.52-0.455.14M4.35M
2026-04-15-0.58-0.493.82M7.10M
2025-11-19-0.49-0.536.78M7.10M
2025-08-19-0.55-0.273.82M3.65M
2025-05-15-0.45-0.443.02M3.67M
2025-03-31-0.28-0.433.70M3.89M
2024-11-14-0.40-0.703.86M3.89M
2024-08-14-0.60-1.054.05M3.60M
2024-05-14-1.63-1.173.42M3.41M
2024-03-28-3.05-1.903.25M3.41M
2023-11-14-1.75-3.123.30M4.50M
2023-08-16-3.75-3.753.40M4.14M
2023-06-08-1.72-0.183.86M4.01M
2023-03-30-5.00-5.503.95M4.25M
2022-12-20-8.25-0.284.25M3.72M
2022-08-23-8.27—4.18M3.81M
2022-05-16-6.50-6.503.46M4.44M
2022-03-31-8.50-6.254.40M4.85M
2021-11-15-6.50-4.004.55M4.50M
2021-08-12-4.75-4.004.50M4.50M
2021-05-17-4.75-4.253.45M—
2021-03-25-12.00-5.253.31M—
2020-12-14-3.63—3.29M—
2020-06-30-2.83—3.27M—
2020-03-31-5.17—3.20M—
2019-12-31-5.28—3.06M—
2019-09-30-6.24—3.32M—
2019-06-30-5.65—2.51M—
2019-03-31-5.65—2.51M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-14Krammer Anja BBuy12.00K$0.182.16K
2026-09-14Lindsay Mark F.Buy12.00K$0.182.16K
2026-09-14Green Ralph EliasBuy12.00K$0.182.16K
2026-09-14SOKOLOW LEONARD JBuy12.00K$0.182.16K
2026-09-14JOHNSON GREGG CBuy12.00K$0.182.16K
2026-07-31Amman Bradford K.Buy150.00K$0.4161.50K
2026-07-31Amman Bradford K.Buy250.00K$0.41102.50K
2026-06-30Huntsman Ronald KirkBuy85.91K$0.5850.00K
2026-06-30Huntsman Ronald KirkBuy85.91K$0.5850.00K
2026-06-30Skaff Michael CBuy1.89M$0.46861.91K
2026-06-30Skaff Michael CBuy2.75M$0.461.25M
2026-06-30Skaff Michael CBuy859.17K$0.46391.78K
2026-06-30V-Co Investors 4 LLCOther2.75M$0.461.25M
2026-06-30V-Co Investors 4 LLCOther2.75M$0.461.25M
2026-03-31V-Co Investors 3 LLCOther0——
2026-03-31V-Co Investors 3 LLCOther1.78M$1.091.94M
2026-03-31V-Co Investors 3 LLCOther429.96K$0.0043
2026-03-31V-Co Investors 3 LLCOther1.78M$1.091.94M
2026-03-31Skaff Michael CBuy1.78M$1.091.94M
2026-03-31Skaff Michael CBuy1.78M$1.091.94M
2026-03-31Skaff Michael CBuy308.85K$1.34413.86K
2026-03-31Skaff Michael CBuy1.04M$1.341.40M
2026-03-31Skaff Michael CBuy429.96K$0.0043
2026-02-04JOHNSON GREGG COther0——
2025-06-09Skaff Michael COther0——
2025-06-09Skaff Michael COther0——
2025-06-09Skaff Michael COther2.33M$2.235.20M
2025-06-09Skaff Michael COther725.26K$0.0073
2024-11-26Huntsman Ronald KirkBuy315.42K$2.64832.71K
2024-11-26Amman Bradford K.Buy149.53K$2.64394.77K
2024-06-20Huntsman Ronald KirkBuy20.00K$2.3847.60K
2024-06-20SOKOLOW LEONARD JBuy4.00K$2.389.52K
2024-06-20Thompson MatthewBuy4.00K$2.389.52K
2024-06-20Green Ralph EliasBuy4.00K$2.389.52K
2024-06-20Krammer Anja BBuy4.00K$2.389.52K
2024-06-20Amman Bradford K.Buy15.00K$2.3835.70K
2024-06-20Lindsay Mark F.Buy4.00K$2.389.52K
2024-06-10Skaff Michael COther3.22M$2.207.10M
2023-06-20Huntsman Ronald KirkBuy14.00K$0.537.42K
2023-06-16Huntsman Ronald KirkBuy5.00K$0.532.65K
2023-06-16Huntsman Ronald KirkBuy10.00K$0.545.40K
2023-06-15Huntsman Ronald KirkBuy21$0.5010
2023-06-14Huntsman Ronald KirkBuy10.00K$0.494.90K
2022-12-23Krammer Anja BBuy30.00K$0.4814.40K
2022-12-23SOKOLOW LEONARD JBuy30.00K$0.4814.40K
2022-12-23Thompson MatthewBuy30.00K$0.4814.40K
2022-12-23Huntsman Ronald KirkBuy150.00K$0.4872.00K
2022-12-23Huntsman Ronald KirkBuy333.33K$0.48160.00K
2022-12-23Huntsman Ronald KirkBuy20.00K$0.5010.00K
2022-12-23Lindsay Mark F.Buy30.00K$0.4814.40K
2022-12-23Amman Bradford K.Buy200.00K$0.4896.00K
2022-12-23Green Ralph EliasBuy30.00K$0.4814.40K
2022-05-31Huntsman Ronald KirkBuy8.00K$2.0316.24K
2022-02-25Huntsman Ronald KirkBuy125.00K$3.27408.75K
2022-02-25Amman Bradford K.Buy50.00K$3.27163.50K
2021-09-21Huntsman Ronald KirkBuy5.00K$4.3121.55K
2021-08-31Amman Bradford K.Buy50.00K$5.26263.00K
2021-08-17Huntsman Ronald KirkBuy5.00K$3.0015.00K
2021-08-05Thompson MatthewBuy30.00K$2.7281.60K
2021-08-05Green Ralph EliasBuy30.00K$2.7281.60K
2021-08-05Krammer Anja BBuy30.00K$2.7281.60K
2021-08-05Singh Gurdev DaveBuy30.00K$2.7281.60K
2021-08-05Lindsay Mark F.Buy30.00K$2.7281.60K
2021-08-05SOKOLOW LEONARD JBuy30.00K$2.7281.60K
2021-06-16Huntsman Ronald KirkBuy125.00K$5.64705.00K
2021-05-25Amman Bradford K.Buy1.00K$5.295.29K
2021-05-25Huntsman Ronald KirkBuy4.00K$5.3821.52K
2021-03-12Amman Bradford K.Buy100.00K$7.50750.00K
2021-03-12Amman Bradford K.Buy100.00K$7.50750.00K
2020-12-24Amman Bradford K.Buy1.00K$7.387.38K
2020-12-23Huntsman Ronald KirkBuy1.00K$7.277.27K
2020-12-11Huntsman Ronald KirkBuy500$8.504.25K
2020-12-10Huntsman Ronald KirkOther0——
2020-12-10SOKOLOW LEONARD JSell16.67K$7.50125.00K
2020-12-10Thompson MatthewSell16.67K$7.50125.00K
2020-12-10Singh Gurdev DaveOther0——
2020-12-10Singh Gurdev DaveSell0——
2020-12-10Green Ralph EliasSell16.67K$7.50125.00K
2020-12-10Amman Bradford K.Sell16.67K$7.50125.00K
2020-12-10Huntsman Ronald KirkOther0——
2020-12-10Huntsman Ronald KirkSell333.33K$1.65550.00K
2020-12-10Lindsay Mark F.Sell16.67K$7.50125.00K
2020-12-10Krammer Anja BSell16.67K$7.50125.00K
2019-11-18Amman Bradford K.Buy16.67K$7.50125.00K
2018-10-22Amman Bradford K.Buy83.33K$7.50625.00K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 22, holders -1 vs prior quarter. Ownership 3.00%.

HolderSharesChangeChange %Value
GEODE CAPITAL MANAGEMENT, LLC85.00K-10.54K-11.03%38.63K
IHT WEALTH MANAGEMENT, LLC76.74K35.67K+86.88%34.88K
VANGUARD CAPITAL MANAGEMENT LLC60.63K-212.70K-77.82%27.59K
COMMONWEALTH EQUITY SERVICES, LLC42.50K00.00%19.32K
B. RILEY WEALTH ADVISORS, INC.38.07K00.00%18.77K
UBS GROUP AG39.15K28.11K+254.46%17.82K
CENTURION WEALTH MANAGEMENT LLC35.68K00.00%16.22K
BLACKROCK, INC.27.82K00.00%12.64K
STATE STREET CORP24.92K00.00%11.33K
SEQUOIA FINANCIAL ADVISORS, LLC24.00K00.00%10.91K
VANGUARD FIDUCIARY TRUST CO23.43K-7.40K-24.00%10.66K
NORTHERN TRUST CORP20.77K8.26K+66.05%9.44K
ACORN WEALTH ADVISORS, LLC14.78K00.00%6.72K
SUSQUEHANNA INTERNATIONAL GROUP, LLP10.07K10.07KNew4.58K
TOWER RESEARCH CAPITAL LLC (TRC)5.21K-2.18K-29.47%2.37K
OSAIC HOLDINGS, INC.1.14K00.00%516
SIGNATUREFD, LLC54700.00%249
INTEGRATED WEALTH CONCEPTS LLC320320New144
BLUE TRUST, INC.16000.00%73
KOZAK & ASSOCIATES, INC.4900.00%24
GLOBAL RETIREMENT PARTNERS, LLC2323New10
MORGAN STANLEY700.00%3
XTX TOPCO LTD0-25.12K-100.00%0
ARMISTICE CAPITAL, LLC0-1.12M-100.00%0
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO0-3-100.00%0

Earnings and financials

Vivos Therapeutics, Inc. (VVOS) trades at $0.12, with a market cap of $1.71M and a trailing P/E of -0.06. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

20182019202020212022202320242025
379226111393277130660001688500016024000138010001503100017443000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Vivos Therapeutics (VVOS) Financials: Revenue & Earnings

VVOS$0.12-0.01 -3.90%

$1.71M

Market Cap

-0.06

P/E

—

Forward P/E

58

Score

Price History